Replicon Team

 

Petteri Hirvonen, M.Sc. (Econ.), MBA (Biotech Management, Finance)
CEO, Senior Partner

(PLEASE NOTE: Currently Petteri works fulltime as the CEO and CSO of Replicon Health Ltd. He can handle client cases of Replicon Group very limitedly. Only cases that directly complement his activities in Replicon Health and simultaneously the client can be considered.)

Petteri Hirvonen (b. 1963) heads Replicon Group and has operations responsibility in valuations, planning of financial transactions and in business strategy of growth companies. Mr Hirvonen has more than 20 years of significant experience in strategic and statistical analyses, valuations and investment management. During last ten years he has been involved in numerous strategy and business planning projects related to Cleantech and HealthBio -sector companies. Additionally he has acted as investment director, financial analyst and economist in many leading companies in Finland. He possesses deep understanding of reduced/smart mathematical modeling of ultra complicated systems (econometrics/biometrics), valuations, economics and molecular physiology of energy metabolism.

Prior to starting as a fulltime employee in Replicon in 2003 Petteri Hirvonen was a Senior Partner and Chief Investment Officer at Mandatum Asset Management as well as the Chief Economist of Mandatum Bank. Before joining Mandatum, Mr. Hirvonen was affiliated with DavyProtos Ltd, Finnish Export Credit (1 billion euro of stocks and bonds under management) and Kansallis Bank in various positions of investing, financing, and research operations. During late 1980's Mr. Hirvonen acted as a researcher in the Research Institute of Finnish Economy (ETLA).

Before his work-life Petteri Hirvonen graduated from the University of Helsinki in 1988 (MSc(Econ)). He started his university studies in Law School and he has also completed studies in Mathematical faculty of the University of Helsinki. Mr. Hirvonen has lectured several university level courses in statistics. Additionally in 2003 he received an MBA degree from Helsinki School of Economics with two majors: Finance and Biotech Management.